KALV · Insider trading · 13F holders · Congress trades
KalVista Pharmaceuticals, Inc. (KALV)
Who is buying and selling KALV: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 1
KALV at a glance
- No open-market insider purchases or sales of KALV were filed in the last 90 days.
- No 13F filer reports KALV among its 50 largest positions.
- Members of Congress have disclosed 1 KALV trade since 2022, 1 purchase and 0 sales in the past year; the latest was Chris Jacobs (R-NY), buying $1K–15K on Dec 12, 2022.
- KALV last closed at $27.00 on Jun 10, 2026.
KALV insider trading
No open-market insider purchases or sales of KALV were filed in the last 90 days.
Who owns KALV? Hedge funds and superinvestors
No 13F filer reports KALV among its 50 largest positions.
KALV stock trades by members of Congress
Members of Congress have disclosed 1 KALV trade since 2022, 1 purchase and 0 sales in the past year; the latest was Chris Jacobs (R-NY), buying $1K–15K on Dec 12, 2022.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Jan 20, 2023 | Chris JacobsR-NY · House | Buy | $1K–15K | Dec 12, 2022 | — |
KALV questions and answers
Are insiders buying KALV stock?
No open-market insider purchases or sales of KALV were filed in the last 90 days.
Which hedge funds own KALV?
No 13F filer reports KALV among its 50 largest positions.
Has Congress traded KALV?
Members of Congress have disclosed 1 KALV trade since 2022, 1 purchase and 0 sales in the past year; the latest was Chris Jacobs (R-NY), buying $1K–15K on Dec 12, 2022.
Cite or share this
Free to use with a link back. The data updates every filing day.